Publications & Tools
Center for Global Health Informational Brochure
Resources and Tools
Responsible Conduct of Research Training materials, "The Right Choice."
This series of videos were produced to trigger discussion during training about responsible conduct of research. Videos address selected training topics specified by the National Institutes of Health and are informed by themes identified by researchers in Africa. A Facilitator guide is available in English and French. The videos are available in English and with French subtitles.
- The Right Choice Facilitator Guide (English)
Le choix approprié Guide de l'animateur
- The Right Choice (Responsible Conduct of Research Training): "What's Ours is Yours!"
- The Right Choice (Responsible Conduct of Research Training): "Plagiarism? Only Technically..."
- The Right Choice (Responsible Conduct of Research Training): "Make Me an Author!"
- The Right Choice (Responsible Conduct of Research Training): "Data Sharing: It's Not What It Used To Be…"
Dr. Robert Murphy, Director of the Center for Global Health, was mentioned in The Economist article "No hiding place: The long-sought goal of a cure for AIDS is inching closer."
The Center for Global Health's latest award, the Medical Education Partnership Initiative in Nigeria (MEPIN), has recieved a lot of news coverage, including the following:
- NU News
- Daily Northwestern
- Feinberg News
- Molecular Station Science News
September 30, 2010
Dr. Babafemi Taiwo, Director of Research in Africa for the Center for Global Health, was quoted in the WebMD.com article Advances in HIV Treatment: How AIDS Cocktails Work.
Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping LH, Athreya GS, Treurnicht FK, Keele BF, Wood N, Salazar-Gonzalez JF, Bhattacharya T, Chu H, Hoffman I, Galvin S, Mapanje C, Kazembe P, Thebus R, Fiscus S, Hide W, Cohen MS, Karim SA, Haynes BF, Shaw GM, Hahn BH, Korber BT, Swanstrom R, and Williamson C. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol 83: 3556-3567, 2009.
Achenbach C, Cole S, Kitahata M, Casper C, Willig J, Mugavero M, Saag M. Mortality after cancer diagnosis in HIV-infected individuals treatedwith antiretroviral therapy. AIDS, 2011 Mar 13; 25 (5):691-700. PMCID: 21160411
Achenbach C, Darin K, Murphy R, Katlama C. Atazanavir/ritonavir based combination antiretroviral therapy for treatment of HIV-1 infection in adults. Future Virology, 2011 Feb; 6 (2):157-177.
Achenbach C, Harrington R, Dhanireddy S, Crane H, Capser C, Kitahata M. Paradoxical immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin Infect Dis. 2011 (in press).
Achenbach CJ, Scarsi KK, and Murphy RL. Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV. Adv Ther 27: 1-16, 2010.
Agbaji O, Agaba P, Taiwo B, Idoko J, Ekong E, Murphy R, Kanki P. Temporal change in glomerular function associated with the use of tenofovir disoproxil fumarate in HIV infected Nigerians. West African Journal of Medicine. Accepted December 9, 2010.
Armstrong C, Liu E, Okuma J, Spiegelman D, Chalamilla G, Njelekela M, Grinspoon S, Fawzi W, Hawkins C. Dyslipidemia in an HIV-positive, antiretroviral treatment-naïve population in Dar es Salaam, Tanzania. In press, JAIDS
Cadmus SIB, Jenkins AO, Godfroid J, Osinusi K, Adewole IF, Murphy RL, Taiwo B. Mycobacterium tuberculosis and Mycobacterium africanum in stools from children attending an immunization clinic in Ibadan, Nigeria. Int J of Infectious Dis. 2009 November, 13(6): 740-744.
Campion S, Cohen MS, McMichael A, Galvin S, Goonetilleke N. Improved detection of latent Mycobacterium tuberculosis infection in HIV-1 infected individuals using cultured cellular assays. Eur J Immunol Nov 2010: 41(1):255-7.
Chalamilla G, Hawkins C, Okuma J, Spiegelman D, Aveika A, Christian B, Koda H, Kaaya, S, Mtasiwa D, Fawzi W For the MDH Tanzania HIV/AIDS Program. Mortality and Treatment Failure among HIV-infected adults in Dar es Salaam, Tanzania. In press, Journal of the International Association of Physicians in AIDS Care
Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, Kourtis AP,et al for BAN Study Group. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med Jun 2010:362(24), pp 2271-81.
Farr SL, Nelson JA, Ng'ombe TJ, Kourtis AP, Chasela C, Johnson JA, et al for BAN Study Team. Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi. J Acquir Immune Defic Syndr Aug 2010:54(5), pp 515-23.
Fehintola FA, Akinyinka OO, Adewole IF, Maponga CC, Ma Q, Morse GD. Drug interactions in the treatment and chemoprophylaxis of malaria in HIV infected individuals in sub Saharan Africa. Current Drug Metabolism. 2011 Jan;12(1):51-56.
Galvin S, de Vries DH, Mhlanga M, Cindzi B, Dlamini T. Access barriers to HIV/AIDS care among health care workers in Swaziland. JIAS In Press 2011.
Galvin S, Robertson R, Hargarten S. Injuries Occurring in Medical Students during International Medical Rotations: A Strategy towards Maximizing Safety. Family Medicine. In Press 2011.
Garcia M, Li M, Siril H, Hawkins C, Kaaya S, Ismail S, Chalamilla G, Hirschhorn L. Health care worker-reported factors associated with quality of care and engagement in quality improvement in HIV clinics, Dar es Salaam, Tanzania. International Journal for Quality in Health Care, 2011, March 26th, 1-8
Hawkins C, and Murphy RL. Management of antiretroviral failure and resistance in developing countries. Curr Opin HIV AIDS 4: 538-544, 2009.
Hawkins CA, Chaplin B, Idoko J, Ekong E, Adewole I, Gashau W, Murphy RL, and Kanki P. Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria. J Acquir Immune Defic Syndr 52: 228-234, 2009.
Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankale JL, Ekong E, Murphy R, Kanki P, and Thio CL. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis 49: 1268-1273, 2009.
Kitahata M, Achenbach C, Saag M. Letters: Age at Cancer Diagnosis Among Persons with AIDS. Ann Intern Med, 2011 May 3; 154:642-643.
Lamorde M, Byakika-Kibwika P, Okaba-Kayom V, Flaherty JP, Boffito M, Namakula R, Ryan M, Nakabiito C, Back DJ, Khoo S, Merry C, Scarsi KK. Suboptimal Nevirapine Steady-State Pharmacokinetics During Intrapartum Compared With Postpartum in HIV-1-Seropositive Ugandan Women. J Acquir Immune Defic Syndr. 2010 Jul 8. [Epub ahead of print]
Liu E, Semu H, Hawkins C, Chalamilla G, Akum A, Spiegelman D, Mehta S, Mtasiwa D, Fawzi W. Nutritional status and mortality among HIV-infected patients on antiretroviral therapy in Tanzania. In Press, JID
Hawkins C, Chalamilla G, Okuma J, Spiegelman D, Hertzmark E, Aris E, Ewald T, Mugusi F, Mtasiwa D, Fawzi W. Gender Differences in Antiretroviral Treatment Outcomes among HIV-infected Adults in Dar es Salaam, Tanzania. In press, AIDS
Murphy RL, Autran B, Katlama C, Brucker G, Debre P, Calvez V, Clotet B, Clumeck N, Costagliola D, Deeks SG, Dorrell L, Gatell J, Haase A, Klein M, Lazzarin A, McMichael AJ, Papagno L, Schacker TW, Wain-Hobson S, Walker BD, and Youle M. A step ahead on the HIV collaboratory. Science 324: 1264-1265, 2009.
Murphy RL, Berzins B, Zala C, Fichtenbaum C, Dube MP, Guaraldi G, Torriani F, Belsey E, Mitchell C, and Stein JH. Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy. Aids 24: 885-890, 2010.
Murphy RL, Kivel NM, Zala C, Ochoa C, Tharnish P, Mathew J, Pascual ML, and Schinazi RF. Antiviral activity and tolerability of amdoxovir with zidovudine in a randomized double-blind placebo-controlled study in HIV-1-infected individuals. Antivir Ther 15: 185-192, 2010.
Musa J, Taiwo B, Goldsmith S, Sutton S, Berzins B, and Murphy RL. Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes. Arch Gynecol Obstet 2010.
O'Donnell EP, Scarsi KK, Darin KM, Gerzenshtein L, Postelnick MJ, Palella FJ. Low incidence of renal impairment observed in tenofovir-treated patients. J Antimicrob Chemother. 2011 May;66(5):1120-6.
Papagno L, Alter G, Assoumou L, Murphy R, Garcia F, Clotet B, Larsen M, Braibant M, Marcelin A-G, Costagliola D, Altfeld M, Katlama C, Autran B, and the ORVACS Study Group (Berzins B). Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine. AIDS 2011; 25:27-36.
Peppard SR, Scheetz MH, Postelnick MH, Darin KM. The impact of qualitative respiratory cultures on mortality in critically ill patients with hospital-acquired pneumonia. Hospital Pharmacy. 45(8):624-633 (2010).
Robertson K, Kumwenda J, Supparatpinyo K, Jiang J, Evans S, Campbell T, Price R, Murphy R, Hall C, Marra C, Marcus C, Berzins B, Masih R, Santos B, Silva M, Kuarasamy N, Walawander A, Nair A, Tripathy S, Kanyama C, Hosseinipour M, Montano S, La Rosa A, Amod F, Sanne I, Firnhaber C, Hakim J, Brouwers P. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected patients in diverse resource-constrained settings. J NeuroVirology 2011 Jul 23.
Ryscavage P, and Galvin S. Papular purpuric gloves and socks syndrome due to Parvovirus B19 infection: A case report and review. Infectious Diseases in Clinical Practice 18: 128-131, 2010.
Sacktor N, Miyahara S, Deng L, Evans S, Schifitto G, Cohen BA, Paul R, Robertson K, Jarocki B, Scarsi K, Coombs RW, Zink MC, Nath A, Smith E, Ellis RJ, Singer E, Weihe J, McCarthy S, Hosey L, Clifford DB; On behalf of the ACTG A5235 team. Minocycline treatment for HIV-associated cognitive impairment: Results from a randomized trial. Neurology. 2011 Sept 7. [epub ahead of print]
Siril H, Hirschhorn L, Hawkins C, Garcia M, Li, M, Ismail S, Mdingi S, Chalamilla G, Fawzi W, Kaaya S. Stress, motivation and professional satisfaction among Health Care Workers in HIV Care and Treatment Centers in Urban Tanzania. In press, East African Journal of Public Health
Taiwo B. Adherence to antiretroviral therapy: the more you look, the more you see. Curr Opin HIV AIDS 4: 488-492, 2009.
Taiwo B. Understanding transmitted HIV resistance through the experience in the USA. Int J Infect Dis 13: 552-559, 2009.
Taiwo B, Chaplin B, Penugonda S, Meloni S, Akanmu S, Gashau W, Idoko J, Adewole I, Murphy R, and Kanki P. Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1. Curr HIV Res 8: 194-198, 2010.
Taiwo BO, Idoko JA, Welty LJ, Otoh I, Job G, Iyaji PG, Agbaji O, Agaba PA, and Murphy RL. Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting. J Acquir Immune Defic Syndr 54: 85-92, 2010.
Taiwo B, Zheng L, Gallien S, Matining R, Kuritzkes D, Wilson C, Berzins B, Acosta E, Bastow B, Kim P, Eron J, and ACTG A5262 Team. Efficacy of a Nucleoside-sparing Regimen of Darunavir/Ritonavir Plus Raltegravir in Treatment-Naïve HIV-1-infected Patients (ACTG A5262). AIDS. 2011 Nov 13;25(17):2113-2122.
This page last updated Nov 27, 2012